·
2 Min Read

July 2, 2021: State Advocacy Update

Colorado regulation will measure SUD network adequacy and more in the latest State Advocacy Update.

Advocacy Update
Bryan Alexander, PharmD; Alëna Balasanova, MD; VaKara Meyer Karre, MD; Nico Cortes-Penfield, MD
·
4 Min Read

How one Nebraska addiction psychiatrist advocates for her patients

An addiction psychiatry consultation-liaison service is becoming an increasingly important part of the University of Nebraska Medical Center’s culture.

Behavioral Health
Open doors of a cell in a correctional facility or prison.
·
4 Min Read

Require access to Rx for opioid-use disorder in prisons, jails

Delegates seek to ensure that evidence-based treatment for substance-use disorders, along with social support, is available in correctional facilities and upon release.

Population Health
·
2 Min Read

AMA calls for access to substance use disorder treatment in prisons, jails

Access to medication treatment in correctional facilities is not only protected by the law, but it is essential.

Press Releases
Naloxone spray
·
3 Min Read

Biden administration boosts access to overdose prevention, treatment

The drug-overdose epidemic continues during the COVID-19 pandemic, but steps are being taken that will save lives and enhance access to treatment.

Behavioral Health
·
3 Min Read

May 21, 2021: State Advocacy Update

Sterile needle and syringe exchange bill headed to Arizona governor and more in the latest State Advocacy Update.

Advocacy Update
Man in a mask, in a prison cell
·
5 Min Read

Why denying addiction treatment in jails, prisons is inhumane

Evidence shows medications to treat substance-use disorder treatment in jails and prisons are lifesaving, yet they’re too often denied. Learn more with the AMA.

Population Health
Pedestrians crossing the street
·
4 Min Read

Removing stigma, advancing evidence-based care at Mount Sinai

Learn about an innovative primary care program at the New York hospital that helps people with opioid-use disorder get the care they need.

Behavioral Health
·
1 Min Read

AMA statement on FDA decision on naloxone nasal

AMA commends FDA’s approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose.

Press Releases